Preclinical Modelling - Centre for Biomedical Technologies

Accelerating access to safer, more effective and cost-efficient medical solutions

Improving patient outcomes

Preclinical modelling gives researchers and clinicians the power to predict how treatments will perform before they reach people. More effective and accurate models allow clinicians to test proposed therapies, like biomedical devices or drugs, so they can find the right treatment at the right time for the right patient. Researchers can optimise new drugs and devices using computer simulations or 3D tissue or organ models that are safer, faster, more accurate, less costly and reduce the need for animal testing. Better models ensure only the most promising treatments advance into human clinical trials – saving time and resources while improving patient outcomes.

Transforming research into real-world solutions

We develop a variety of next-generation preclinical models to improve patient outcomes.

We discover, develop and deliver the next frontier of biomedical technologies for better patient treatment and quality of life.

Our approach includes:

computer simulations to improve cancer treatments and radiation targeting
AI-powered models that predict disease progression, reduce complications and optimise therapies
3D tissue and organ models for testing drugs and regenerative solutions for bone trauma
patient-specific simulations to guide surgery and design custom implants
real-world refinement of models through surgical validation and implant testing
computer and “patient-on-a-bench” models to investigate artificial heart performance under a range of physiological conditions
fundamental research into biomechanics, cellular and tissue biology to inform accurate models.